Table 6.
Comparison of miRNA profiles in tissue and plasma
| Tissue | Plasma | |
|---|---|---|
| BE/SQ | BE/controls | |
| hsa-miRNA-194-5p | 36.02 | 2.17 |
| hsa-miRNA-451a | 3.97 | 1.83 |
| hsa-miRNA-133b | 3.11 | 0.58 |
| hsa-miRNA-1-3p | 2.64 | 0.56 |
| hsa-miRNA-10a-5p | 2.24 | 0.55 |
| EAC/SQ | EAC/controls | |
|---|---|---|
| hsa-miRNA-194-5p | 18.62 | 2.21 |
| hsa-miRNA-365a-3p | 0.45 | 0.62 |
| hsa-miRNA-133b | 2.58 | 0.65 |
| hsa-miRNA-1-3p | 2.31 | 0.44 |
| EAC/BE | EAC/BE | |
|---|---|---|
| hsa-miRNA-451a | 0.48 | 0.61 |
MiRNAs more than twofold up- or down-regulated comparing tissue samples and miRNAs more than 1.5-fold up- or down-regulated comparing plasma samples from esophageal adenocarcinoma (EAC), Barrett’s esophagus (BE), and controls are shown
BE Barrett’s esophagus, SQ squamous epithelium, EAC esophageal adenocarcinoma